These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 39090674)
21. In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach. Al-Asmari AK; Ullah Z; Al Balowi A; Islam M Int J Nanomedicine; 2017; 12():559-574. PubMed ID: 28144138 [TBL] [Abstract][Full Text] [Related]
22. Synthesis, Characterization, and In-Vitro Evaluation of Silibinin-loaded PEGylated Niosomal Nanoparticles: Potential Anti-Cancer Effects on SW480 Colon Cancer Cells. Alali U; Mohammed Kadhim Al-Tu'ma M; Fadhil Jawad A; Talib Ahmed S; Addai Ali H; Abdulzehra S; Jawad Al-Tu'ma F Asian Pac J Cancer Prev; 2024 Jul; 25(7):2539-2550. PubMed ID: 39068589 [TBL] [Abstract][Full Text] [Related]
23. Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Sharifi-Azad M; Kaveh Zenjanab M; Shahpouri M; Adili-Aghdam MA; Fathi M; Jahanban-Esfahlan R Biomed Mater; 2024 Jul; 19(5):. PubMed ID: 38953496 [TBL] [Abstract][Full Text] [Related]
24. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. Gao Y; Zhou S; Xu Y; Sheng S; Qian SY; Huo X Nitric Oxide; 2019 Feb; 83():33-39. PubMed ID: 30590117 [TBL] [Abstract][Full Text] [Related]
26. Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells. Firouzi Amandi A; Jokar E; Eslami M; Dadashpour M; Rezaie M; Yazdani Y; Nejati B Med Oncol; 2023 May; 40(6):170. PubMed ID: 37156929 [TBL] [Abstract][Full Text] [Related]
27. pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy. Khodabakhsh F; Bourbour M; Yaraki MT; Bazzazan S; Bakhshandeh H; Ahangari Cohan R; Tan YN Molecules; 2022 Aug; 27(17):. PubMed ID: 36080186 [TBL] [Abstract][Full Text] [Related]
28. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression. Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667 [TBL] [Abstract][Full Text] [Related]
29. Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines. Pourmoghadasiyan B; Tavakkoli F; Beram FM; Badmasti F; Mirzaie A; Kazempour R; Rahimi S; Larijani SF; Hejabi F; Sedaghatnia K Mol Biol Rep; 2022 May; 49(5):3597-3608. PubMed ID: 35235156 [TBL] [Abstract][Full Text] [Related]
30. Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells. Quagliariello V; Masarone M; Armenia E; Giudice A; Barbarisi M; Caraglia M; Barbarisi A; Persico M Oncol Rep; 2019 Mar; 41(3):1476-1486. PubMed ID: 30569138 [TBL] [Abstract][Full Text] [Related]
31. Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected]. Xiao X; Liao X; Qiu S; Liu Z; Du B; Xu S Mar Drugs; 2014 Aug; 12(8):4521-38. PubMed ID: 25231922 [TBL] [Abstract][Full Text] [Related]
32. Preparation, Optimization and In vitro Evaluation of Doxorubicin-loaded into Hyaluronic Acid Coated Niosomes Against Breast Cancer. Faddah H; Nsairat H; Shalan NM; El-Tanani M; Alqudah DA; Alshaer W Chem Biodivers; 2024 Feb; 21(2):e202301470. PubMed ID: 38161147 [TBL] [Abstract][Full Text] [Related]
33. Oxaliplatin-incorporated micelles eliminate both cancer stem-like and bulk cell populations in colorectal cancer. Wang K; Liu L; Zhang T; Zhu YL; Qiu F; Wu XG; Wang XL; Hu FQ; Huang J Int J Nanomedicine; 2011; 6():3207-18. PubMed ID: 22238509 [TBL] [Abstract][Full Text] [Related]
34. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice. Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338 [TBL] [Abstract][Full Text] [Related]
35. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer. Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316 [TBL] [Abstract][Full Text] [Related]
37. Enhanced in vitro and in vivo anticancer activity through the development of Sunitinib-Loaded nanoniosomes with controlled release and improved uptake. Dehghan S; Naghipour A; Anbaji FZ; Golshanrad P; Mirazi H; Adelnia H; Bodaghi M; Far BF Int J Pharm; 2023 Jun; 640():122977. PubMed ID: 37121495 [TBL] [Abstract][Full Text] [Related]
38. Niosomes nanoparticles as a novel approach in drug delivery enhances anticancer properties of chrysin in human ovarian carcinoma cells (SKOV3): an in vitro study. Tarahomi M; Firouzi Amandi A; Eslami M; Yazdani Y; Salek Farrokhi A; Ghorbani F; Taherian M; Yousefi B Med Oncol; 2023 Feb; 40(3):87. PubMed ID: 36723692 [TBL] [Abstract][Full Text] [Related]
39. Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment. Sorasitthiyanukarn FN; Muangnoi C; Ratnatilaka Na Bhuket P; Rojsitthisak P; Rojsitthisak P Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():178-190. PubMed ID: 30274050 [TBL] [Abstract][Full Text] [Related]
40. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]